Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria (Q34035602)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria |
scientific article |
Statements
1 reference
Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria (English)
1 reference
Bernhard Resch
1 reference
Constanze Sommer
1 reference
Mark J C Nuijten
1 reference
Susanne Seidinger
1 reference
Evelyn Walter
1 reference
Vera Schoellbauer
1 reference
Wilhelm D Mueller
1 reference
1 January 2012
1 reference
1 reference
Identifiers
1 reference